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Xmrk encodes a subclass 1 receptor tyrosine ldnase 
(RTK) which has been cloned from the melanoma-
inducing locus Tu of the poecilüd fisb Xiphophorus. To 
demonstrate a high oncogenic potential in vivo we trans-
ferred the gene into early embryos of the closely related 
medakafish. Ectopic expression of tbe Xmrk oncogene 
under the control of a strong, constitutive promoter 
(CMVTk) led to the induction of embryonic tumors witb 
high incidence, after sbort latency periods, and witb a 
specific pattem of aß'ected tissues. We demonstrate 
ligand-dependent transformation in vivo using a chimeric 
receptor consisting of the extracellular and transmem-
brane domains of tbe human EGF receptor (HER) and 
the cytoplasmatic domain of Xmrk. Expression of tbe 
chimeric receptor alone does not lead to ldnase activa-
tion or induction of tumors. Coexpression of tbe chimera 
witb its corresponding ligand, human transforming 
growtb factor alpha (bTGF(X), however, results in tbe 
activation of tbe chimeric RTK. In injected fish embryos 
tbe induction of tbe neoplastic growtb is observed witb 
similar incidence and tissue distribution as in embryos 
carrying tbe native Xmrk oncogene suggesting tbat tbe 
ligand as weil as factors downstream of tbe RTK are 
required for tumor formation. In this study we show 
single-step induction of tumors by ectopic expression of 
RTKs in vivo substantiating tbe significance of autocrine 
stimulation in RTK induced tumors in vertebrales. 
Introduction 
Receptor tyrosine kinases (RTKs) have been im-
plicated in cell transformation and human cancer. 
While activating mutations in RTK-derived oncogenes 
appear to correlate with their transforming potential, 
the most common cellular lesion found in human 
cancers seems to involve autocrine activation of 
overexpressed receptors (Ullrich & Schlessinger, 1990): 
many tumors and tumor-derived cell lines have been 
found to coexpress growth factors and their receptors. 
However, the functional significance of this correlative 
observation for the primary steps in tumor develop-
ment remained to be elucidated. lt was shown that 
NIH3T3 cells overexpressing the human epidermal 
gtowth factor (EGF) receptor (HER) developed a fully 
transformed phenotype in vitro that required both 
functional HER expression and the presence of EGF in 
the growth medium (DiFiore et a/., 1987; Velu et al., 
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1987). Experiments in vivo demonstrating ligand-
dependent tumor induction by an overexpressed RTK, 
thereby substantiating the concept of autocrine 
stimulation of tumor cell growth, are still lacking. To 
address the significance of autocrine activation of 
RTKs in the induction of cancer, we used the Xmrk-
RTK oncogene from the poeciliid fish Xiphophorus 
macu/atus. 
Melanoma formation in Xiphophorus is a paradig-
matic case for hereditary cancer (Friend, 1993). Since 
60 years this model has been used for the analysis of 
the factors that are instrumental for tumor formation. 
Early genetic work resulted in the definition of a 
melanoma-inducing locus, Tu, under the control of a 
regulating tumor suppressor locus, R (Ahuja & Anders, 
1976). The Xmrk gene, which was identified by 
methods of positional cloning (Wittbrodt et a/., 1989), 
is encoded by Tu. lt is required for tumor formation, 
as insertional disruption of this oncogene abolishes its 
melanoma-inducing capacity. The structural analysis of 
the Xmrk oncogene compared to its proto-oncogenic 
counterpart, as weil as studies on expression and trans-
criptional control have indicated that overexpression of 
Xmrk may be the prerequisite mechanism for its 
oncogenic activity (Adam et a/., 1991, 1993). This 
poses the question whether overexpression of Xmrk by 
itself is sufficient to evoke the füll neoplastic 
phenotype. As the ligand for the Xmrk R TK is 
unknown, we have previously analysed a chimeric 
receptor consisting of the HER extracellular and trans-
membrane domains and the Xmrk tyrosine kinase 
domain. Experiments in vitro and in tissue culture 
showed the ligand dependent activation of the Xmrk 
kinase (Wittbrodt et a/., 1992). In order to correlate 
such ligand dependent RTK activation in vitro with the 
process of neoplastic transformation and tumor induc-
tion in vivo we have attempted to perforrn gene transfer 
of the chimeric receptor in conjunction with its 
activating growth factor. 
Small aquarium fish species such as the medaka or 
the zebrafish, because of their translucent embryos, 
offer the possibility to study the mechanisms of normal 
embryonic development (Marcey & Nüsslein-Volhard, 
1986; Rossant & Hopkins, 1992). They are similarly 
suited to study phenomena that appear during this 
early phase of ontogenesis. Based on the assumption 
that overexpression of R TKs and their corresponding 
ligands, both of which are presumed to participate in 
regulating normal embryogenesis, might lead to 
phenotypic effects that occur in early phases of 
development, gene transfer studies were performed in 
the medakafish (Oryzias latipes). Cytoplasmic injection 
of foreign genes into early embryos led to transient 
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expression of the encoded proteins that was promoter-
specific and stable for up to 4 weeks (Chong & Viel-
kind, 1989; Winkler et a/., 1991, 1992). This experi-
mental system allows an efficient analysis of a large 
number of animals expressing the transgene during the 
entire embryogenesis and larval development. 
In this work we have used gene transfer in a smaU 
aquarium fish species to show single-step induction of 
tumors of the R TK oncogene Xmrk and growth factor-
dependent tumorigenesis by a HERfXmrk chimeric 
RTK coexpressed with a cognate ligand, human tumor 
growth factor oc (hTGFoc). 
Results 
Transient expression of foreign DNA infish embryos in 
vivo 
In previous studies we showed that plasrnid DNA 
injected cytoplasmatically into one cell of the two-cell 
stage embryo of medakafish persists extrachromosom-
ally throughout embryonic and larval development 
(Winkler et a/., 1991 , 1992). Due to the uneven dis-
tribution of the injected DNA during rapid cell 
divisions in the early fish embryo, the spatial pattern of 
reporter gene expression was highly mosaic. Injection 
of reporter genes revealed specific temporal expression 
patterns strictly dependent on the promoter-enhancer 
combinations used. This work defined the cytomegalo-
virus enhancer added to the Herpes simplex virus 
thymidine kinase promoter (CMVTk) as a strong pro-
moter driving the expression of reporter genes at 
invariably high levels from late blastula onwards to 
posthatching stages. In order to define the spatial pat-
tern of the CMVTk enhancer-promoter activity and to 
determine the degree of mosaicism of expression we 
injected the lacZ reporter gene under the control of 
CMVTk and analysed the spatial expression pattems 
by immunohistochernistry in embryos of early organo-
genesis stage (Figure 1). Whole mount immunofluores-
cence staining with an anti-ßGal antibody revealed 
expression of the injected gene in small groups of cells 
of the embryo. Screening large numbers of embryos we 
could not find any restriction of CMVTk activity to 
specific cell types or organs of the developing embryo. 
Moreover we found ubiquitous activity of this 
heterologous promoter in vivo, e.g. in cells of the 
developing retina, in neurons of the CNS or in groups 
of epidermal cells (Figure 1 ). 
Ectopic expression of Xmrk oncogene Leads to neoplastic 
lesions during embryogenesis of medakafish 
To address the question if overexpression of Xmrk 
alone is sufficient for tumor induction, we constructed 
a minigene under the control of the cytomegalovirus 
enhancer/thyrnidine kinase promoter (CMVTk) consist-
ing of Xmrk cDNA sequences isolated from melanoma 
cells that were fused within the kinase domain to the 
corresponding 3' genornic sequence (Figure 2). When 
compared with the control, pCMVTk Xmrk-injected 
embryos exhibited a considerably increased frequency 
of early embryonic lethality, abnormal development, 
and malformations (Table 1). Abnormalities generally 
resulted from disorganization of developing organs, 
Figure 1 Transient expression of the lacZ reporter gene in 3 day 
old medaka embryos, that were injected cytoplasmatically at the 
two-cell stage with an expression vector containing the lacZ gene 
under the control of the cytomegalovirus (CMV) enhancer in 
combination with the Herpes simplex virus thymidine-kinase (Tk) 
promoter. Immunostaining of whole mount preparations using a 
monoclonal anti-lacZ antibody shows single lacZ expressing cells 
in the developing retina (a: marked by arrowheads), groups of 
expressing neuronal cells in the embryonic brain (b) and clusters 
of epidermal cells in the trunk region (c) of a medaka embryo at 
the early organogenesis (stage 28). L: Jens; R: retina; B: brain. 
Scale bars represent 25 µm (a,b) and 50 µm (c) 
primarily affecting the brain and eye. The apparent 
predominance of effects on the development of certain 
organs may possibly be interpreted on the basis of the 
specific differential expression characteristics of the cor-
responding endogeneous Xmrk proto-oncogene during 
embryogenesis (Wittbrodt et al.,1989; Winkler & 
Schartl, manuscript in preparation). 
In addition to embryonic lethality and abnormal 
organ development, we observed the formation of 
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Figure 2 Receptor expression constructs used for injection containing the cytomegalovirus (CMV) enhancer in combination with 
the Herpes simplex virus thymidine-kinase (Tk) promoter. (a) Map of pCMVTk Xmrk. The 5' translated region of the 
Y-chromosomal cDNA encoding the Xmrk receptor tyrosine kinase isolated from melanoma cells was fused within the kinase 
domain to the corresponding genomic sequence. The original 5' EcoRI restriction site is absent due to blunt end ligation, as 
indicated (AE). (b) Map of pCMVTk HER{Xmrk. To obtain expression of a chimeric RTK, a 2.2 kb Xbaf/Narl cDNA fragment 
encoding the extracellular and transmembrane domain of the human EGF receptor was introduced into the vector described in a to 
replace the corresponding Xmrk domains (for details see Materials and methods). The original 5' Xbal site is absent, as indicated 
(AX) 
Table 1 Tumor induction in fish embryos after gene transfer of the Xmrk oncogene and 
cotransfer of the HER/Xmrk chimera and hTGF11 
Malformations and 
Early embryonic early abnormal Neoplastic 
Total lethals development groll'th 
pCMVTkXmrk 528 188 (35.6%) 108 (20.5%) 45 (8.5%) 
pCMVTk HER/Xmrk 278 24 (8.6%) 27 (9.7%) 4 (1.4%) 
pCMVTk HER/Xmrk and 659 198 (30.0%) 150 (22.8%) 76 (11.5%) 
pSVhTGfo 
pSV hTGfo 199 64 (32.2%) 45 (22.6%) 0 (-) 
pCMVTkCAT 122 8 (6.6%) 15 (12.3%) 0 (-)* 
*[n earlier experiments with more than 3000 medaka embryos injected with constructs containing 
the bacterial reporter genes CAT and lacZ in combination with various promoter-enhancer 
sequences, including SV40, CMV and RSV, not a single tumor was detected. Under the conditions 
used expression of the transgene occurs in 95% of the injected embryos (Winkler et al., 1991, 
1992). Roughly equal copy numbers of each construct were injected according to the procedure 
described (Winkler et al .. 1991) 
Table 2 Developing organs affected by neoplastic growth 
Brain Retina 
pCMVTkXmrk 6 7 
pCMVTk HER/Xmrk 4 II 
and pSV hTGF11 
*Cysts and hyperplastic growth 
tumorous lesions at a high frequency (tumors in 45 
(13.2%) of 340 embryos surviving at organogenesis 
stage; 8.5% of injected embryos). None of these 
phenomena have been observed in uninjected or 
control plasmid-injected embryos (Table l ). pCMVTk 
Xmrk-injected embryos developed reproducibly abnor-
mal outgrowths at the late organogenesis stages (5-6 
days of development), which originated at different 
sites and in different embryonal organs (Figure 3, 
Table 2). Approximately half of the lesions represented 
epithelial hyperplasias of sometimes remarkable dimen-
sions, reaching in some cases up to about 15% of the 
entire embryo size. They occurred mainly in the integu-
ment, but sometimes also in the interior, where they 
impeded the normal development of surrounding tis-
sues and organs. 
Interestingly, tumors occurred only in those organs 
Integument Pigment cel/s Epithelia* Total 
8 1 23 45 
10 2 49 76 
120 
that were found to express the Xmrk proto-oncogene, 
like the developing brain, the embryonic retina and the 
integument (Winkler & Schart!, manuscript in prepara-
tion), although expression of the transgene protein 
product was detected immunohistochemically in tu-
morous as weil as in no tumorous embryonic tissues. 
Such tissues included also those that normally do not 
express the Xmrk proto-oncogene (Figure 3). This 
confirms the ubiquitous activity of the promoter used 
for Xmrk transgene expression. To test, whether the 
restriction of tumor development to specific tissues is 
due to the localized presence of an activating growth 
factor and/or to the restricted function of the down-
stream signalling pathway in specific tissue types, we 
studied the ligand dependency of tumor formation by 
ectopically expressing a HER/Xmrk chimeric receptor 
together with its activating ligand, hTGFcx. 
1520 C. WINKLER et a/. 
Cotransfection with pSVhTGFa. /eads to activation of 
the HER/Xmrk chimera in vitro 
To study ligand-dependent transformation, we em-
ployed a chimeric receptor consisting of the extracel-
lular and transmembrane domains of the human EGF 
receptor (HER) and the cytoplasmic domain of Xmrk 
(Wittbrodt et a/., 1992). The HER/Xmrk chimera has -
been demonstrated previously to be functional in vitro 
and in human embryonal kidney fibroblasts (293 cells), 
as addition of hEGF to the medium resulted in 
autophosphorylation of the receptor itself and tyrosine 
phosphorylation of potential candidate substrates. 
Activation of the kinase domain was strictly ligand-
dependent (Wittbrodt et a/., 1992). 
To verify that coexpression of a growth factor and 
the chimera also generates a physiological signal we 
performed cotransfection of 293 cells with the receptor 
Figure 3 Noninjected control (a,b,c) and Xmrk transgenic (b,d,e) medaka embryo (stage 35) that was injected cytoplasmatically 
with pCMVTk Xmrk into one cell of the two-cell stage embryo. Note expansive growth of the developing brain in the 
Xmrk-injected embryo (b), leading to a latero-rostral dislocation of the eyes. Parafrontal sections (c,d) revealed uncontrolled growth 
in the dorsal region of the brain (see d), leading to distortion of the normal architecture of the central nervous system. Proliferation 
of undifferentiated cells disrupted the ventricular system (e). In frontal sections the morphology is essentially normal in the more 
ventral region of the brain, except for the dislocated eyes. Scale bars represent 50 µm (c,d) and 10 µm (e) 
encoding plasmid pCMVTk HERfXmrk together with 
a plasmid encoding one of its cognate ligands, hTGFcx. 
Autophosphorylation was monitored by immunopre-
cipitation of metabolically labeled proteins with the 
anti-phosphotyrosine antibody cxPY. Coexpression of 
receptor and growth factor in 293 cells led to activa-
tion of the R TK at similar levels as the addition of 
hEGF to the medium (Figure 4). RTK activation was 
also obtained when medium conditioned by cells, tran-
siently expressing pSV TGFcx, was used to stimulate 
the cells transfected with pCMVTk HERfXmrk alone. 
Incubation of mock transfected cells with hEGF or 
TGFcx conditioned medium did not result in any detec-
table phosphorylation of proteins in the size range of 
the receptor chimera (165 kDa). These data showed 
that both vectors intended to be used for gene transfer 
experiments into fish embryos express functional pro-
teins and are suitable to obtain ligand dependent recep-
tor activation. This provides the tools to activate 
autologous Xmrk signaling pathways in the cells of the 
injected embryo by stimulation with ectopically coex-
pressed human TGFcx. 
Ligand dependent induction of embryonic tumors by 
ectopic coexpression of HER/Xmrk and hTGFcx in vivo 
Injection of pCMVTk HER/Xmrk alone into two-cell 
stage medaka embryos resulted in a dramatic decrease 
of phenotypic effects during early embryo development 
and in a significant reduction in tumor incidence when 
compared with embryos injected with pCMVTk Xmrk 
(Table 1). The chimeric receptor, however, was abun-
dantly and ubiquitously expressed, as shown by 
immunohistochemistry (Figure 5). We observed tu-
morous lesions only in four out of 278 injected emb-
ryos all of which were characterized as epithelial 
hyperplasia of the integument ('cysts'). 
Expression of the corresponding ligand hTGFcx 
alone resulted in a high incidence of early em-
IP: aPY 
pCMVTk 
mock HER/Xmrk 
EGF + + 
TGFa supernatant + 
pSVTGFa + + 
--165 kDa 
Figure 4 Ligand dependent receptor autophosphorylation in 
vitro. Equal numbers of 293 cells untransfected ('mock'), trans-
fected with pCMVTk HERfXmrk alone or cotransfected with 
pSV TGFat were metabolically labeled with pss]methionine and 
were incubated in the presence ( +) or absence ( - ) of 50 ng mJ- 1 
EGF or with the supematant of 293 cells transiently transfected 
with pSV TGFat. Tbc cell lysates were used for immunoprecipita-
tion with a monoclonal antibody directed against phosphotyro-
sine ('atPY'). Tue molecular weight of the signal representing the 
phosphorylated form of the receptor chimera is indicated in kDa 
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bryological defects. However, tumorous lesions were 
not observed at all. 
Coinjection of the TGFcx expression plasmid and the 
plasmid directing expression of the HER/Xmrk 
chimera into fish embryos resulted in the induction of 
tumors with high frequency and short latency period 
comparable to tumor induction following overexpres-
sion of the native Xmrk oncogene (Table l ). The rate 
of incidence was even higher as compared to the native 
Xmrk oncogene. In a total of 461 embryos surviving at 
organogenesis stage we observed neoplastic lesions in 
76 cases (16.5%; 11.5% of injected embryos), whereas 
the incidence was 13.2% with the native Xmrk 
oncogene. Despite the ectopic expression of the 
activating ligand, the tumors obtained in these 
experiments were of the same histiotype as observed in 
Xmrk injected embryos (Table 2). As with Xmrk more 
than half of the lesions observed in the coinjected 
embryos affected epithelia by cystic and hyperplastic 
growth. 
Discamion 
We have used a novel experimental system to study the 
function of oncogenes in vertebrates by a transgenic 
model. Small aquarium fish, like the Japanese medaka 
(0. latipes), provide a promising and powerful system 
to analyse the regulation and functional significance of 
potentially oncogenic genes for the process of tumor 
formation. They are easy to breed in the laboratory, 
have a short generation time and produce large 
amounts of eggs perfectly suited for gene transfer by 
microinjection. The high transparency of the extemally 
developing embryos allows an easy observation in situ 
at the single cell level of the complete embryonic 
development of large numbers of embryos. Cytoplas-
mic injection of plasmid DNA into one cell of the 
two-cell stage medaka embryo results in transient ex-
pression of the injected gene during embryogenesis 
with a spatial expression pattem, that is highly mosaic. 
This provides an important advantage of transient 
transgenic systems compared to stable transgenic 
animals when oncogenes are analysed for their func-
tion in spontaneous tumorigenesis (Weinberg, 1989). In 
stable transgenic animals virtually all cells of a given 
tissue express the activated oncogene instead of small 
isolated groups of activated oncogene-bearing cells that 
interact with non-transformed neighbour cells. The 
mosaic pattem of expression in the transient medaka 
expression system, however, mimics the actual situation 
of tumorigenesis in situ, where an initiated cell or cell 
clone is in contact with a normal, non-transformed 
environment. 
In this study, we demonstrate that the Xmrk gene 
which has previously been shown to be required for 
melanoma formation in the poeciliid fish Xiphophorus 
is also sufficient for induction of the neoplastic 
phenotype of certain cells. Using gene transfer into 
early fish embryos we could show that ectopic expres-
sion of this RTK under the control of a strong, ubi-
quitously active promoter resulted in the induction of 
tumorous growth already during embryonic develop-
ment. The short latency period of 4-6 days and the 
high frequency of tumor incidence, which ranged.from 
10-20% in independent experirnents (Table 1 and data 
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Figure 5 (A) Imrnunohistochemical detection of HER{Xmrk protein expression in non-tumorous medaka embryos that were 
injected with pCMVTk HER/Xmrk at the two-cell stage. (a) Whole mount preparation of the trunk region of an injected embryo, 
stage 28. The non-homogeneous pattern of expression is due to the mosaic distribution of the injected DNA as a general feature of 
the transient in vivo expression system (Winkler et al„ 1991, 1992). (b) Higher magnification view of a showing single mesenchymal 
cells expressing the chimeric receptor. (c) Paraffin section of the peduncular region of a tumor free stage 33 embryo. Arrows 
indicate the cell surface expression of the transgene protein in clusters of mesenchymal cell. Scale bars represent 50 µm (a) and 
10 µm (b,c). (B) Tumor-bearing medaka embryo (stage 34) coinjected with pCMVTk HER/Xmrk and pSV TGF« at the two-cell 
stage showing nodular tumorous growth caudal of the right eye. (a) Nomarski image of a cryostat frontal section depicting an 
not shown), suggests a dominant role for the Xmrk 
gene in the oncogenic events leading to tumor forma-
tion. The results with many other oncogenes tested in 
transgenic animals are in line with a multistep process 
of cancer development, involving several mutational 
events that are necessary for induction and main-
tenance of the neoplastic phenotype (reviewed in 
Vogelstein & Kinzler, 1993). In contrast, our results 
provide evidence that an activated RTK oncogene 
alone might lead to cancer with only few, if any addi-
tional events required. Our findings are consistent with 
the effect of an activated neu oncogene in transgenic 
mice, which at high frequency led to the development 
of mammary tumors (Muller et a/. , 1988). This 
confirms the possibility of a dominant role for tyrosine 
kinase oncogenes in tumorigenesis. Overexpression of 
the nonactivated, proto-oncogenic form of neu also 
resulted in tumors in transgenic mice, however with 
frequencies lower and latency periods longer than with 
the activated form (Guy et al. , 1992), indicating that 
overexpression of a RTK alone might not be sufficient 
for the inductive event. At present, it remains unclear, 
whether in our studies the transforming capacity of the 
overexpressed Xmrk was due to activating mutations in 
the oncoprotein or to the simultaneous expression of 
the as yet unidentified Xmrk ligand in embryonic tis-
sues. The Xmrk oncogene shows a low level of con-
sti tutive autophosphorylation activity after transfection 
into heterologous expression systems (Wittbrodt et a/., 
1992). Whether this is the effect of an activating muta-
tion in the extracellular or transmembrane domains, 
and what the significance for tumor induction might 
be, can only be answered after the Xmrk proto-onco-
gene is available for comparative expression studies. 
To approach the question of ligand dependent tumor 
induction in vivo we analysed the tumorigenic capacity 
of a receptor chimera consisting of the HER extracel-
lular and transmembrane domain and the Xmrk 
kinase. Our previous studies bad shown that this recep-
tor, combining mammalian with fish domains, is func-
tional in vitro (Wittbrodt et a/. , 1992). Moreover, this 
chimera showed a high transforming activity in the 
focus formation assay, when transfected into NIH3T3 
cells in the presence of the inducing ligand, hEGF. No 
focus formation was observed without the addition of 
hEGF or after transfection of the wildtype Xmrk, 
showing that transformation by this RTK is ligand-
dependent in the context of a heterologous in vitro 
system. 
Injection of the chimeric receptor into early medaka 
embryos resulted in a very low tumor incidence in the 
absence of its corresponding ligand. However, the 
receptor was abundantly expressed, as shown by 
immunohistochemistry (Figure 5). The low frequency 
induction of tumorous lesions may have been caused 
by either the presence of a fish growth factor binding 
with low affinity to the HER extracellular domain, thus 
activating the Xmrk cytoplasmic domain, or the 
ligand-independent activation of the RTK signaling 
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potential due to high level overexpression. Embryos 
that were injected with pSVhTGF« alone exhibited a 
high incidence of early embryological defects. This sug-
gested the possibility of human TGF« activation of an 
endogeneous RTK that is crucial in early developmen-
tal stages. No tumors, however, were detected in later 
embryonic stages, larvae or young fish. In the mouse, 
ectopic expression of TGF« after gene transfer into the 
germ line led to predisposition for the development of 
tumors of various histological types (Jhappan et al., 
1990; Matsui et a/., 1990; Sandgren et a/., 1990; Takagi 
et a/., 1992). Tumor development, however, only occur-
red in adult animals, which suggested the necessity of a 
second event in addition to growth factor overexpres-
sion. 
Coexpression of the HER/Xmrk receptor and 
hTGF« resulted in the induction of tumorous growth 
with a high incidence and short latency period com-
parable to the results obtained by plasmid-mediated 
Xmrk oncogene overexpression (Table 1). The tumors 
observed in both sets of experiments showed the same 
tissue distribution (Table 2). In the neu-oncogene car-
rying transgenic mice the tissue specificity of malignant 
tumor development, namely restriction to the mam-
mary gland, was due to the promoter specificity direc-
ting neu expression, although an influence of the tissue 
context was noted (Muller et a/. , 1988). However, in 
the experiments reported here, an ubiquitously active 
promoter was used, that led to RTK expression in a 
much wider spectrum of cell types and tissues than 
those finally involved in tumorous lesions. This sug-
gests that activation of the cell-specific signaling path-
ways through Xmrk or the HER/Xmrk by either the 
endogenous Xmrk ligand or ectopically expressed 
TGF«, respectively, caused the pathogenic effects. The 
identification and characterization of the Xmrk ligand, 
as weil as the signal transduction machinery down-
stream of this RTK will help to understand the 
activating mechanisms of a RTK, that results in the 
induction of tumor growth in a single step. 
Our results clearly demonstrate the potential of 
RTKs in the in vivo situation, under conditions of 
abnormal overexpression and autocrine activation, to 
induce malignant transformation of normal cells in an 
intact organism. This provides direct evidence for a 
mechanism that has been proposed to be involved m 
the development of cancer in humans. 
Materials and methods 
Embryos 
Medakafish (Oryzias latipes; Teleostei: Cyprinodontidae) 
were purchased from Carolina Biological Supply Company 
(Burlington, North Carolina, USA). Adult fish were main-
tained under standard conditions (Kirchen & West, 1976) 
with an artificial photoperiod (10 h of darkness, 14 h of light) 
to induce reproductive activities. Clusters of fertilized eggs 
were collected 1-2 h after the onset of light and kept in 
encapsulated tumor (marked by arrowheads) adjacent to the eye bulb. (b) Immunohistochemical detection of HER(Xmrk 
expression (marked by arrowheads) in the marginal zone of the lesion. (c) Higher magnification view of the marginal zone. Arrow 
indicates cell surface expression of HER/Xmrk. Scale bars represent 50 µm (a) and 10 µm (c). Sections were treated with a 
monoclonal antibody (MoAb 108.1) directed against the receptor domain of the human EGF receptor. Sections were either 
incubated with a secondary antibody coupled to FITC (A a,b; 8 b,c) or horseradish peroxidase (A c) 
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Yamamoto's saline (0.75% NaCI, 0.02% KCI, 0.02% CaCl2 
pH 7.3; Yamamoto, 1961) prior to injection. lnjected medaka 
embryos were reared in a medium containing 0.1 % NaCI, 
0.003 % KCI, 0.004% CaC!i x 2 H20 , 0.016% MgS04 x 
7 H20 , and 0.0001 % methylene blue and transferred to 
aquarium water immediately after hatching. Embryos were 
staged according to Kirchen and West (1976). 
Expression plasmids 
To analyse transient expression of reporter genes in vivo a 
plasmid was injected into fish embryos containing the ß-
galactosidase (lacZ) gene under the control of the cyto-
megalovirus (CMV) enhancer in combination with the 
Herpes simplex virus thymidine-kinase (Tk) promoter. The 
lacZ gene together with a SV40 polyadenylation sequence 
was removed as XholfK.pnl fragment from the vector pUC-
lac20 (Michiels et al., 1989) and cloned into a pUC 118 
derivative containing the CMVTk promoter/enhancer 
(Friedenreich & Schart!, 1990). 
For expression of the Xmrk oncogene a cDNA containing 
the 5' portion of the translated region of the Y-chromosomal 
encoded Xmrk isolated from melanoma cells was fused 
within the kinase domain (Sacl site at 3016, see Wittbrodt et 
al. , 1989) to the corresponding genomic sequence (Sacl site at 
809, see Adam et al., 1991) to improve the expression in vivo. 
This Xmrk minigene was cloned as a 7.6 kb EcoRI fragment 
in pBluescript II (Stratagene) under the control of the 
CMVTk promoter/enhancer. For expression of the chimeric 
RTK, a HER 2.2 kb Xbal/Narl cDNA fragment originating 
from CMVneoHER (Wittbrodt et al. , 1992) was introduced 
in pCMVTk Xmrk to replace the 5' extracellular and trans-
membrane encoded domains of Xmrk. 
M icroinjection 
Medaka embryos were injected cytoplasmatically into one 
cell of the two-cell stage embryo as previously described 
(Winkler et a/., 1991). Approximately 500 pi (equivalent to 
25 pg) of plasmid DNA were microinjected cytoplasmatically 
into one cell of the two-cell stage embryo. DNA was dis-
solved to a final concentration of 50 µg m1- 1 in Yamamoto 
Ringer saline containing 0.1 % phenol red. Plasmid-DNA was 
injected in either supercoiled or linearized conformation, 
however no significant differences in expression pattems or 
incidence of tumor formations have been observed (data not 
shown, and Winkler et al. (1992) for similar result with 
reporter gene constructs). For linearization the Xmrk 
minigene has been removed from prokaryotic vector 
sequences by digestion with BssHII (see Figure 2). 
Histo/ogy 
For histological examinations embryos were fixed for 24 h in 
Bouin's fixative (saturated picric acid in H20:formaldehyde 
(37%):glacial acidic acid 15:5: !), embedded in paraffin and 
thin sectioned. 10 µm sections were stained with acid 
alizarine blue/anilinblue-orange G and mounted in Entellan 
(Merck). 
For immunohistochemistry embryos were fixed for 12 h at 
4°C in 4% paraformaldehyde in 0.2 M phosphate butfer, 
pH 7.4 (PB). During the washing procedure in PB (three 
times, 5 min each) chorions and yolk sacs were removed. The 
fixed embryos were incubated in 20% sucrose at 4°C over-
night prior to embedding in OCT (Tissue Tek, Miles lnc.). 
10 µm frozen sections were cut on a cryostat and stored at 
- 20°C until staining. For peroxidase staining the air dried 
slides were incubated for 20 min in methanol:3% H20 2 (4: l) 
to block endogeneous peroxidase activity. To prevent un-
specific antibody binding all slides were treated with 1 % 
normal horse serum in PB for 30 min at room temperature. 
The mouse monoclonal antibody MoAb 108. J, directed 
against the extracellular domain of the human EGF receptor 
(Lax et a/. , 1989) was added at a dilution of 1 : 1000 and 
incubated for 60 min. After washing with PB/ I % horse 
serum (three times, 15 min each) sections were incubated with 
a biotinylated secondary horse antimouse IgG diluted 1 :200 
in PB/horse serum for 30 min. After washing slides were 
incubated in a 1 :200 solution of avidin coupled to FITC or 
horseradish peroxidase in PB/horse serum for 30 min. In the 
latter case after washing with PB sections were stained for 
5 min with diaminobenzidine (0.6 mg m1- 1 in PB) sup-
plemented with 0.03% H20 2 and counterstained with a 1 % 
light green solution in water for 10 min. 
For whole mount immunostainings, embryos at early 
organogenesis (stage 28) were fixed in paraformaldehyde as 
above. After washing in PB chorions and yolk sacs were 
removed. Embryos were incubated in a blocking solution 
containing 1 % normal horse serum, l % BSA, 1 % DMSO 
and 1 % Triton X-100 in PB for 30 min at 4°C with gentle 
shaking. The mouse monoclonal antibodies anti-ß- · 
galactosidase (Boehringer Mannheim) or 108.J (Lax et al. , 
1989) were added in a dilution of 1 : 1000 and incubated for 
at least 12 h at 4°C with gentle shaking. After washing with 
blocking solution (four times, 30 min each), embryos were 
treated with a biotinylated secondary horse anti-mouse 
antibody (Vector laboratories)(J :200 in blocking solution) for 
another 12 h at 4°C with shaking. After washing as above 
embryos were finally treated with avidin-FITC (1 :200 dilu-
tion in blocking solution) for 3- 6 h, washed and mounted in 
a medium containing 10% (w/v) polyvinylalcohol, 25% (w/v) 
glycerol and 2.5% l ,4-diazo-bicyclo-(2.2.2)-octane (DABCO) 
in 0.1 M Tris-CI pH 8.5, to reduce fading. 
Metabolie /abeling and immunoprecipitation 
293 human embryonic kidney fibroblasts were transfected 
with expression vectors as previously described (Wittbrodt et 
al„ 1992). Cells were grown in DMEM containing 10% fetal 
calf serum. 24 h after transfection cells were incubated with 
1 ml of methionine-free medium containing 1 % dialyzed fetal 
calf serum, 2 mM L-glutamine, antibiotics and 50 µCi m1 - 1 
(35S)methionine per 3 cm dish. The incubation was continued 
for 16 h. 
For detection of tyrosine phosphorylation, transfected and 
metabolically labeled cells were stimulated for 10 min in the 
presence of 100 ng m1- 1 hEGF, TGFIX and mock conditioned 
medium respectively. Proteins were immunoprecipitated after 
lysis with monoclonal antibody tXPY as described (Wittbrodt 
et al., 1992). Briefly, after lysis of cells supematants were 
incubated on ice for 5 min and then centrifugated at 14 000 g 
for 5 min. The supematants were diluted l : 3 with HNTG 
(20 mM HEPES pH 7.2, 150 mM NaCJ, 10% glycerol and 
0.1 % Triton X-100) supplemented with 100 mM NaF and 
100 µm sodium orthovanadate and incubated with 4 µI IXPY 
antiserum and 20 µI of protein A-Sepharose (! : 1 slurry in 
HNTG buffer) for 2 h at 4°C. The immunoprecipitates were 
washed three times in 0.5 ml HNTG buffer. Samples were 
boiled for 5 min, centrifuged and analysed by fluorography 
after separation on 7.5% SDS-polyacrylamide gels. 
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